<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01481740</url>
  </required_header>
  <id_info>
    <org_study_id>4999-01460</org_study_id>
    <nct_id>NCT01481740</nct_id>
  </id_info>
  <brief_title>Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)</brief_title>
  <official_title>A Double Blind Randomized Controlled Trial of Phenylephrine for the Prevention of Spinal Induced Hypotension in Obese Parturients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IWK Health Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IWK Health Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previous research regarding the use of phenylephrine has excluded obese subjects (BMI &gt;35).
      This subgroup of patients represents a large portion of the obstetric patient population
      locally and nationally. It is unclear whether previous research should be extrapolated to the
      obese patient population. This study is being done to compare the incidence of hypotension,
      intraoperative nausea and vomiting, and neonatal acidosis between obese patients who receive
      a prophylactic phenylephrine infusion versus those who receive phenylephrine boluses for the
      treatment of established hypotension. This study will help us determine whether using a
      phenylephrine infusion or a phenylephrine bolus is the best way to prevent/treat spinal
      induced hypotension during cesarean deliveries in obese patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Nausea and Vomiting</measure>
    <time_frame>intraoperative 2-3 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Nausea and Vomiting</measure>
    <time_frame>2 hrs postoperative</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Nausea and Vomiting</measure>
    <time_frame>24hrs postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Hypotension</measure>
    <time_frame>intraoperative - predelivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Hypotension</measure>
    <time_frame>intraoperative - postdelivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Acidosis</measure>
    <time_frame>intraoperative</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">178</enrollment>
  <condition>Hypotension</condition>
  <arm_group>
    <arm_group_label>Phenylephrine bolus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Phenylephrine infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenylephrine bolus</intervention_name>
    <description>10 ml of 100mcg/ml phenylephrine and placebo infusion</description>
    <arm_group_label>Phenylephrine bolus</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>phenylephrine infusion</intervention_name>
    <description>60ml infusion of 100mcg/ml phenylephrine and placebo bolus</description>
    <arm_group_label>Phenylephrine infusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  English speaking

          -  ASA Physical Status I-II

          -  Non-laboring women

          -  Single gestations â‰¥ 36 weeks

          -  Obese women (Body Mass Index 35 - 55 kg/m2)

          -  Non-emergent CD under spinal anesthesia

        Exclusion Criteria:

          -  Height &lt; 5'0&quot;

          -  Antiemetic drug use in the 24 hours prior to CD

          -  Allergy to phenylephrine, or any other standardized medication

          -  Hypertensive disease of pregnancy (i.e. mild &amp; severe preeclampsia)

          -  Chronic hypertension receiving antihypertensive treatment

          -  Severe Cardiac disease in pregnancy with marked functional limitations

          -  Patients on Monoamine Oxidase Inhibitors or Tricyclic Antidepressants

          -  Subject enrollment in another study involving a study medication within 30 days of CD

          -  Any other physical or psychiatric condition which may impair their ability to
             cooperate with study data collection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald B George, MD FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>IWK Health Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 6K8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2011</study_first_submitted>
  <study_first_submitted_qc>November 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2011</study_first_posted>
  <results_first_submitted>September 14, 2016</results_first_submitted>
  <results_first_submitted_qc>September 14, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 2, 2016</results_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IWK Health Centre</investigator_affiliation>
    <investigator_full_name>Ronald George</investigator_full_name>
    <investigator_title>Primary Investigator, MD, FRCPC, Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>spinal induced hypotension</keyword>
  <keyword>nausea and vomiting</keyword>
  <keyword>cesarean delivery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Phenylephrine Bolus</title>
          <description>Phenylephrine bolus: 10 ml of 100mcg/ml phenylephrine and placebo infusion</description>
        </group>
        <group group_id="P2">
          <title>Phenylephrine Infusion</title>
          <description>phenylephrine infusion: 60ml infusion of 100mcg/ml phenylephrine and placebo bolus</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="90"/>
                <participants group_id="P2" count="88"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="79"/>
                <participants group_id="P2" count="81"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Phenylephrine Bolus</title>
          <description>Phenylephrine bolus: 10 ml of 100mcg/ml phenylephrine and placebo infusion</description>
        </group>
        <group group_id="B2">
          <title>Phenylephrine Infusion</title>
          <description>phenylephrine infusion: 60ml infusion of 100mcg/ml phenylephrine and placebo bolus</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="79"/>
            <count group_id="B2" value="81"/>
            <count group_id="B3" value="160"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32" spread="6"/>
                    <measurement group_id="B2" value="31" spread="5"/>
                    <measurement group_id="B3" value="31" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="79"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="160"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidence of Nausea and Vomiting</title>
        <time_frame>intraoperative 2-3 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine Bolus</title>
            <description>Phenylephrine bolus: 10 ml of 100mcg/ml phenylephrine and placebo infusion</description>
          </group>
          <group group_id="O2">
            <title>Phenylephrine Infusion</title>
            <description>phenylephrine infusion: 60ml infusion of 100mcg/ml phenylephrine and placebo bolus</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Nausea and Vomiting</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence of Nausea and Vomiting</title>
        <time_frame>2 hrs postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine Bolus</title>
            <description>Phenylephrine bolus: 10 ml of 100mcg/ml phenylephrine and placebo infusion</description>
          </group>
          <group group_id="O2">
            <title>Phenylephrine Infusion</title>
            <description>phenylephrine infusion: 60ml infusion of 100mcg/ml phenylephrine and placebo bolus</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Nausea and Vomiting</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence of Nausea and Vomiting</title>
        <time_frame>24hrs postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine Bolus</title>
            <description>Phenylephrine bolus: 10 ml of 100mcg/ml phenylephrine and placebo infusion</description>
          </group>
          <group group_id="O2">
            <title>Phenylephrine Infusion</title>
            <description>phenylephrine infusion: 60ml infusion of 100mcg/ml phenylephrine and placebo bolus</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Nausea and Vomiting</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Hypotension</title>
        <time_frame>intraoperative - predelivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine Bolus</title>
            <description>Phenylephrine bolus: 10 ml of 100mcg/ml phenylephrine and placebo infusion</description>
          </group>
          <group group_id="O2">
            <title>Phenylephrine Infusion</title>
            <description>phenylephrine infusion: 60ml infusion of 100mcg/ml phenylephrine and placebo bolus</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Hypotension</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Hypotension</title>
        <time_frame>intraoperative - postdelivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine Bolus</title>
            <description>Phenylephrine bolus: 10 ml of 100mcg/ml phenylephrine and placebo infusion</description>
          </group>
          <group group_id="O2">
            <title>Phenylephrine Infusion</title>
            <description>phenylephrine infusion: 60ml infusion of 100mcg/ml phenylephrine and placebo bolus</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Hypotension</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neonatal Acidosis</title>
        <time_frame>intraoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Phenylephrine Bolus</title>
            <description>Phenylephrine bolus: 10 ml of 100mcg/ml phenylephrine and placebo infusion</description>
          </group>
          <group group_id="O2">
            <title>Phenylephrine Infusion</title>
            <description>phenylephrine infusion: 60ml infusion of 100mcg/ml phenylephrine and placebo bolus</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Acidosis</title>
          <units>pH value</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="81"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.27" spread="0.06"/>
                    <measurement group_id="O2" value="7.27" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Phenylephrine Bolus</title>
          <description>Phenylephrine bolus: 10 ml of 100mcg/ml phenylephrine and placebo infusion</description>
        </group>
        <group group_id="E2">
          <title>Phenylephrine Infusion</title>
          <description>phenylephrine infusion: 60ml infusion of 100mcg/ml phenylephrine and placebo bolus</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="81"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="81"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Ronald B George</name_or_title>
      <organization>Department of Women's &amp; Obstetric Anesthesia, IWK Health Centre</organization>
      <phone>902-470-6627</phone>
      <email>rbgeorge@dal.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

